Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Hackensack Meridian Health Inc. currently has 3 pending office actions in the Transportation, E-Commerce & Mechanical Systems technology area. These actions are distributed across 3 distinct art units, indicating that the company's patenting efforts in this sector cover a variety of technical applications. The company is working with 3 distinct examiners, meaning each pending action is being reviewed by a different person, which requires a flexible approach to prosecution.
SANGHERA, STEVEN G.S. is the busiest examiner, responsible for 1 pending office action. Because the busiest examiner pending count is only a portion of the 3 total pending actions, the company's prosecution workload is spread evenly across different examiners. This requires a strategy to address the unique requirements of 3 different examiners across 3 different art units within the Transportation, E-Commerce & Mechanical Systems field. The lack of examiner concentration suggests that the company's success is not dependent on any single individual's review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SANGHERA, STEVEN G.S. | 1 | 30.8% | +30.4% |
| ISHIZUKA, YOSHIHISA | 1 | 68.8% | +19.5% |
| CHUNDURU, SURYAPRABHA | 1 | 53.3% | +17.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19066799 | SYSTEMS AND METHODS FOR DYNAMIC INFECTION MONITORING AND TRACKING | SANGHERA, STEVEN G.S. | — |
| 18484324 | PHANTOM AND ASSOCIATED SYSTEMS AND METHODS FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) | ISHIZUKA, YOSHIHISA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19066799 | SYSTEMS AND METHODS FOR DYNAMIC INFECTION MONITORING AND TRACKING | SANGHERA, STEVEN G.S. | — |
| 18484324 | PHANTOM AND ASSOCIATED SYSTEMS AND METHODS FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) | ISHIZUKA, YOSHIHISA | — |
| 18285128 | CDI Rapid Test For COVID-19 Variants of Concern | CHUNDURU, SURYAPRABHA | — |
| Art Unit | Apps |
|---|---|
| 3684 | 1 |
| 2857 | 1 |
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19066799 | SYSTEMS AND METHODS FOR DYNAMIC INFECTION MONITORING AND TRACKING | SANGHERA, STEVEN G.S. | 3684 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18484324 | PHANTOM AND ASSOCIATED SYSTEMS AND METHODS FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) | ISHIZUKA, YOSHIHISA | 2857 | §103§112 | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18285128 | CDI Rapid Test For COVID-19 Variants of Concern | CHUNDURU, SURYAPRABHA | 1671 | §103 | Non-Final OA | — | Pending | Sep 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial